Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add filters








Language
Year range
1.
Chinese Journal of Biochemical Pharmaceutics ; (6): 280-281, 2017.
Article in Chinese | WPRIM | ID: wpr-620570

ABSTRACT

Objective To study the influence analysis of patients with anxiety and depression in elderly patients with hypertension antihypertensive effect of psychological intervention combined with Flupentixol and Melitracen Tablets.Methods 60 elderly patients with hypertension accompanied by anxiety and depression in our hospital from January 2014 to December 2016 were selected as the subjects.They were randomly divided into the control group and the experimental group, with 30 patients in each group.The control group was treated with conventional antihypertensive treatment, the experimental group were given psychological intervention combined with treatment of Flupentixol and Melitracen Tablets.The clinical indexes of the experimental group and the control group were compared and analyzed.Results After the corresponding treatment, the effective rate of antihypertensive treatment in the experimental group was 28 cases, and the effective rate of depressurization was 93.3%.The effective rate of antihypertensive treatment in the control group was 21, and the effective rate of antihypertensive treatment was 70%.After treatment, the HAMD score and HAMA score of the experimental group were significantly lower than those before the treatment, and the score of the experimental group was significantly lower than that of the control group, with statistical difference(P<0.05).Conclusion The treatment of elderly hypertensive patients with anxiety and depression in patients with better antihypertensive effect of psychological intervention combined with Flupentixol and Melitracen Tablets, can improve the depression and anxiety of patients in a large extent, high safety, is further applied in clinical significance.

2.
Chinese Journal of Biochemical Pharmaceutics ; (6): 223-225, 2017.
Article in Chinese | WPRIM | ID: wpr-614078

ABSTRACT

Objective To analyse clinical efficacy of Fangfengtongsheng powder combined with Flupentixol and Melitracen tablets in treatment of anorectal neurosis.Methods92 patients with anorectal neurosis from April 2014 to June 2016 were grouped two groups randomly, each with 46 cases.Two groups were treated with Flupentixol and Melitracen tablets and observation group was treated another with Fangfengtongsheng powder.Clinical efficacy of two groups were compared.Results①Total effective rate of observation group was 95.65%,higher than that of control group 78.26% (P<0.05).②After treatment,SAS and SDS score of observation group were lower than that of control group(P<0.05).③After treatment, anal bulge, anal pain, frequent defecation, anal foreign body sensation score and 8 dimensions of SF-36 scale score of observation group were better than that of control group(P<0.05).④The control group had 8.70% adverse reactions, compared with observation group 4.35%, the difference was not statistically significant.ConclusionFangfengtongsheng powder can improve the therapeutic effect of anorectal neurosis on the basis of Flupentixol and Melitracen tablets, relieve the anxiety level and improve the living standard of patients.

3.
Chinese Journal of Biochemical Pharmaceutics ; (6): 104-106, 2017.
Article in Chinese | WPRIM | ID: wpr-659981

ABSTRACT

Objective To analyse the clinical effect of Quantianma capsules combined with flupentixol and melitracen tablets on chronic migraine. Methods 130 patients with chronic migraine were treated with flupentixol and melitracen tablets, were divided into control group and observation group, 65 patients in each group. The observation group were given to Quantianma capsules. Results The effective rate of observation group with 90.77% was higher than control group with 73.85%(P<0.05). After treatment, the number of migraine attacks, duration time, VAS score, HAMA and HAMD score and mean flow velocity of cerebral artery of two groups were lower than pre-treatment and observation group were lower than that of control group(P<0.05). Adverse reactions were similar in the two groups. Conclusion Quantianma capsules can improve the efficacy of treatment of chronic migraine combined with flupentixol and melitracen tablets and improve condition with few adverse effects.

4.
Chinese Journal of Biochemical Pharmaceutics ; (6): 104-106, 2017.
Article in Chinese | WPRIM | ID: wpr-657668

ABSTRACT

Objective To analyse the clinical effect of Quantianma capsules combined with flupentixol and melitracen tablets on chronic migraine. Methods 130 patients with chronic migraine were treated with flupentixol and melitracen tablets, were divided into control group and observation group, 65 patients in each group. The observation group were given to Quantianma capsules. Results The effective rate of observation group with 90.77% was higher than control group with 73.85%(P<0.05). After treatment, the number of migraine attacks, duration time, VAS score, HAMA and HAMD score and mean flow velocity of cerebral artery of two groups were lower than pre-treatment and observation group were lower than that of control group(P<0.05). Adverse reactions were similar in the two groups. Conclusion Quantianma capsules can improve the efficacy of treatment of chronic migraine combined with flupentixol and melitracen tablets and improve condition with few adverse effects.

5.
Journal of Kunming Medical University ; (12): 72-74, 2016.
Article in Chinese | WPRIM | ID: wpr-514100

ABSTRACT

Objective To investigate the improvement and safety of the conventional treatment combined with Deanxit in the treatment of digestive adverse (FD) of gastrointestinal symptoms and sleep efficacy.Methods Ninety cases of patients with FD were randomly divided into the control group (pantoprazole capsule and Mosapride will + Capsule associated with sleep disorders with estazolam tablets) and observation group (pantoprazole capsule and Mosapride will + capsule with sleep disorders and estazolam tablets plus Deanxit).Both groups were treated for 4 weeks.After the course of treatment,the improvement degree and adverse reaction of digestive tract symptoms and sleep were compared between the two groups.Results After 4 weeks of treatment in the observation group with gastrointestinal symptoms were improved and the total effective rate was 86.7%,higher than that of the control group (66.7%).The difference was statistically gigmificart (P < 0.05).The total effective rate of was sleep disorders improvement 83.3%,higher than that of control group (61.9%),but the difference was not statistically significant (P > 0.05).Adverse reaction rates were not significantly different between the two groups.Conclusion On the basis of conventional therapy,treatment of functional dyspepsia (FD) with Deanxit can significantly alleviate gastrointestinal symptoms.Medication after 3-7 days can relieve the symptoms.After 4 weeks,the total efficiency is the highest with fewer adverse reactions.Clinical application is recommended.

6.
Chinese Journal of Postgraduates of Medicine ; (36): 802-805, 2016.
Article in Chinese | WPRIM | ID: wpr-497392

ABSTRACT

Objective To investigate the clinical effect of flupentixol and melitracen tablets combined with macrogol 4000 powders on treatment of irritable bowel syndrome with constipation (IBS-C) in elderly patients. Methods Fifty paients aged from 65 to 95 years with IBS-C were randomly divided into 2 groups: control group (23 patients) and treatment group (27 patients). The patients in treatment group received flupentixol and melitracen tablets (1 tablets, once a day) combined with macrogol 4000 powders (1 bag/time, 2 times a day) , while the patients in control group received macrogol 4000 powders alone. The treatment period was 4 weeks. The curative effect, the scores of self-rating depression scale (SDS) and self-rating anxiety scale (SAS) and adverse reaction were compared between two groups. Results At the improvement of depressive symptoms, the effective rate in treatment group and control group was 88.9%(24/27) and 39.1%(9/23), and there was significant difference (P<0.01). At the improvement of anxiety symptoms, the effective rate in treatment group and control group was 74.1%(20/27) and 26.1%(6/23), and there was significant difference (P<0.01). The total effective rate in treatment group and control group was 88.9%(24/27) and 65.2%(15/24), and there was significant difference (P<0.05). Conclusions Flupentixol and melitracen tablets combined with macrogol 4000 powders on treatment of aged IBS-C patients have more distinguished therapeutic effect in improving constipation symptoms, stools times, anxiety and depression.

7.
Chinese Journal of Biochemical Pharmaceutics ; (6): 113-115, 2015.
Article in Chinese | WPRIM | ID: wpr-484982

ABSTRACT

Objective To investigate clinical effect of shenlingbaizhu powder combined with flupentixol and melitracen tablets in treatment of spleen deficiency and liver stagnation type IBS-D.Methods 70 cases of liver depression and spleen deficiency type diarrhea predominant IBS patients were selected and in accordance with the principle of random number were divided into observation group and control group, 35 cases in each group, control group was treated with shenlingbaizhupowder treatment, observation group was given shenlingbaizhu powder combined with flupentixol and melitracen tablets treatment,clinical curative effect between two groups was compared.Results The effective rate of the observation group was 91.43%, was higher than that of control group 77.14% (P<0.05).After treatment, the SDS score and SAS score of the two groups were improved (P<0.05), and the improvement effect of observation group was more obvious ( P <0.05 ) .Conclusion Shenlingbaizhu powder combined with flupentixol and melitracen tablets has good effect in treatment of liver depression and spleen deficiency type IBS-D, it is worthy of clinical application.

8.
Clinical Medicine of China ; (12): 1273-1275, 2013.
Article in Chinese | WPRIM | ID: wpr-439801

ABSTRACT

Objective To investigate the therapeutic effect of flupentixol and melitracen tablets for irritable bowel syndrome (IBS).Methods Relevant concerned with the therapeutic effect of Flupentixol and melitracen tablets and routine medicine were reviewed by China national knowledge infrastructure.All reviewed literatures were accessed by Jadad quality scale.Statistic data was analysed by RevMan5.0 and Stata.Results Twelve articles of randomized controlled trial were collected.Among these study,there were 1384 patients,which divided into treatment group (n =704) and control group (n =680).The results of heterogeneity showed that x2 =25.48,P =0.008,I2 =57%.Therefore the random effects model was selected.The combined relative risk is 1.39 and the 95% CI was 1.27-1.53.Conclusion Compared with traditional treatment,flupentixol and melitracen tablets can obviously improve the therapeutic effect of IBS.

9.
China Pharmacy ; (12)1991.
Article in Chinese | WPRIM | ID: wpr-533300

ABSTRACT

OBJECTIVE:To explore a comprehensive drug quality evaluation method so as to provide constructive suggestions for the production and quality inspection of drugs.METHODS:The quality inspection data of 198 batches of flupentixol and melitracen tablets collected automatically by Laboratory Information Management System(LIMS) in Guangdong institute for drug control in 2008 were analyzed statistically,and the drug quality indexes were computed and the drug quality was analyzed comprehensively.RESULTS:Of all the quality items,the content uniformity showed the maximum impact on the quality of the tablets,followed by the content determination item,with disintegration time item showing the least impact on the quality of the tablets.CONCLUSIONS:LIMS is a powerful tool in collecting large quantities of drug data,and the quality index serves as an effective means for the evaluation of drug quality.

SELECTION OF CITATIONS
SEARCH DETAIL